THERAPEUTIC POTENTIAL OF HPMPC AS AN ANTIVIRAL DRUG

[51] A RANDOMIZED, CONTROLLED TRIAL OF PROPHYLACTIC GANCICLOVIR FOR CYTOMEGALOVIRUS PULMONARY INFECTION IN RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (15) : 1005 - 1011

[52] COMPARATIVE INHIBITORY EFFECTS OF NUCLEOSIDE ANALOGS ON DIFFERENT CLINICAL ISOLATES OF HUMAN CYTOMEGALOVIRUS INVITRO [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) : 270 - 275

[53] TREATMENT OF MURINE CYTOMEGALOVIRUS INFECTIONS IN SEVERE COMBINED IMMUNODEFICIENT MICE WITH GANCICLOVIR, (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE, INTERFERON, AND BROPIRIMINE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 1837 - 1842

[54] (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE, A POTENT AND SELECTIVE INHIBITOR OF HUMAN CYTOMEGALO-VIRUS REPLICATION [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (12) : 1839 - 1844

[55] EVALUATION OF INFREQUENT DOSING REGIMENS WITH (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE (S-HPMPC) ON SIMIAN VARICELLA INFECTION IN MONKEYS [J]. ANTIVIRAL RESEARCH, 1991, 16 (01) : 17 - 28

[56] RAT CYTOMEGALOVIRUS-INDUCED PNEUMONITIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EFFECTIVE TREATMENT WITH (S)-1-(3-HYDROXY-2-PHOSPHONYL-METHOXYPROPYL)CYTOSINE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) : 218 - 223

[57] COMPARATIVE ACTIVITY OF (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE AND 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE AGAINST RAT CYTOMEGALOVIRUS-INFECTION INVITRO AND INVIVO [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2262 - 2266

[58] A PROTEIN-KINASE HOMOLOG CONTROLS PHOSPHORYLATION OF GANCICLOVIR IN HUMAN CYTOMEGALOVIRUS-INFECTED CELLS [J]. NATURE, 1992, 358 (6382) : 162 - 164

[59] USSERY FM, 1988, OPHTHALMOLOGY, V95, P640

[60] CHRONIC HERPETIC INFECTION IN AN IMMUNOCOMPROMISED PATIENT - REPORT OF A CASE [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1987, 45 (08) : 723 - 728

[51] A RANDOMIZED, CONTROLLED TRIAL OF PROPHYLACTIC GANCICLOVIR FOR CYTOMEGALOVIRUS PULMONARY INFECTION IN RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (15) : 1005 - 1011

[52] COMPARATIVE INHIBITORY EFFECTS OF NUCLEOSIDE ANALOGS ON DIFFERENT CLINICAL ISOLATES OF HUMAN CYTOMEGALOVIRUS INVITRO [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) : 270 - 275

[53] TREATMENT OF MURINE CYTOMEGALOVIRUS INFECTIONS IN SEVERE COMBINED IMMUNODEFICIENT MICE WITH GANCICLOVIR, (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE, INTERFERON, AND BROPIRIMINE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 1837 - 1842

[54] (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE, A POTENT AND SELECTIVE INHIBITOR OF HUMAN CYTOMEGALO-VIRUS REPLICATION [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (12) : 1839 - 1844

[55] EVALUATION OF INFREQUENT DOSING REGIMENS WITH (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE (S-HPMPC) ON SIMIAN VARICELLA INFECTION IN MONKEYS [J]. ANTIVIRAL RESEARCH, 1991, 16 (01) : 17 - 28

[56] RAT CYTOMEGALOVIRUS-INDUCED PNEUMONITIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EFFECTIVE TREATMENT WITH (S)-1-(3-HYDROXY-2-PHOSPHONYL-METHOXYPROPYL)CYTOSINE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) : 218 - 223

[57] COMPARATIVE ACTIVITY OF (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE AND 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE AGAINST RAT CYTOMEGALOVIRUS-INFECTION INVITRO AND INVIVO [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2262 - 2266

[58] A PROTEIN-KINASE HOMOLOG CONTROLS PHOSPHORYLATION OF GANCICLOVIR IN HUMAN CYTOMEGALOVIRUS-INFECTED CELLS [J]. NATURE, 1992, 358 (6382) : 162 - 164

[59] USSERY FM, 1988, OPHTHALMOLOGY, V95, P640

[60] CHRONIC HERPETIC INFECTION IN AN IMMUNOCOMPROMISED PATIENT - REPORT OF A CASE [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1987, 45 (08) : 723 - 728